Skip to main content
Equibles

BARCLAYS PLC

Position in SMMT — Summit Therapeutics Inc.

CIK 312069 LONDON, X0
Back to SMMT Full portfolio

Position in SMMT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,062,715
+$2,131,723 QoQ
Shares Held
210,207
+328.1% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#56
of 242 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SMMT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,710,275,595 across 454 Biotechnology names. SMMT ranks #53 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 733,274 $364,239,192
2 REGN
Regeneron Pharmaceuticals, Inc.
 256,192 $159,745,957
3 IONS
Ionis Pharmaceuticals Inc
 1,603,136 $127,112,653
4 ARGX
Argenx SE
 134,427 $124,717,337
5 MRNA
Moderna, Inc.
 1,035,126 $72,489,872
6 BBIO
BridgeBio Pharma, Inc.
 714,423 $53,210,224
7 TGTX
Tg Therapeutics, Inc.
 957,848 $52,624,168
8 DNTH
Dianthus Therapeutics, Inc. /DE/
 431,753 $42,087,281

All Filings in SMMT

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,062,715 210,207
2026-03-31 $930,992 49,103
2025-12-31 $5,918,440 338,390
2025-09-30 $9,829,552 475,777
2025-06-30 $6,678,173 313,824
2025-03-31 $4,930,754 255,612
2024-12-31 $5,891,454 330,146
2024-09-30 $5,477,583 250,118
2024-06-30 $3,021,041 387,313
2024-03-31 $1,628,311 393,312
2023-12-31 $831,454 318,565
2023-09-30 $276,789 148,016
2023-06-30 $121,161 48,272
2023-03-31 $431,311 246,464
2022-12-31 $58,900 13,859
2022-09-30 $2,485 2,089
2022-06-30 $1,128 1,128
2022-03-31 $10,683 4,361